1887

Journal of General Virology header logo

Volume 83, Issue 9

Hepatitis C virus core protein represses the p21 promoter through inhibition of a TGF-β pathway Free

Abstract

The increased proliferation rate of hepatocytes is one of the major risk factors for the development of hepatocellular carcinoma. In this study, we investigated the mechanism by which hepatitis C virus (HCV) core protein represses transcription of the universal cyclin-dependent kinase inhibitor p21 gene in murine fibroblast NIH 3T3 cells. From the transient reporter assays of p21 promoter, we found that the TGF-β-responsive element (TβRE) located between −83 and −74 of the p21 promoter is responsible for the effect. The TGF-β-induced p21 promoter activity was specifically decreased by HCV core protein and in the presence of the inhibitory Smad7 the repression effect was almost completely abolished. Furthermore, HCV core protein stimulated the growth rate of NIH 3T3 cells and could overcome growth arrest by TGF-β but not by butyrate, suggesting that HCV core protein stimulates cell cycle progression by repressing p21 transcription through a TGF-β pathway.

  • Received:
  • Accepted:
  • Published Online:
© Microbiology Society
Loading

Article metrics loading...

/content/journal/jgv/10.1099/0022-1317-83-9-2145
2002-09-01
2024-04-25
Loading full text...

Full text loading...

/deliver/fulltext/jgv/83/9/0832145a.html?itemId=/content/journal/jgv/10.1099/0022-1317-83-9-2145&mimeType=html&fmt=ahah

References

  1. Ahn J. Y., Chung E. Y., Kwun H. J., Jang K. L. 2001; Transcriptional repression of p21waf1 promoter by hepatitis B virus X protein via a p53-independent pathway. Gene 275:163–168
     [Google Scholar]
  2. Alexandrow M. G., Moses H. L. 1995; Transforming growth factor beta 1 inhibits mouse keratinocytes late in G1 independent of effects on gene transcription. Cancer Research 55:3928–3932
     [Google Scholar]
  3. Chang J., Yang S. H., Cho Y. G., Hwang S. B., Hahn Y. S., Sung Y. C. 1998; Hepatitis C virus core from two different genotypes has an oncogenic potential but not sufficient for transforming primary rat embryo fibroblasts in cooperation with the H- ras oncogene. Journal of Virology 72:3060–3065
     [Google Scholar]
  4. Cho J. W., Baek W. K., Suh S. I., Yang S. H., Chang J., Sung Y. C., Suh M. H. 2001a; Hepatitis C virus core protein promotes cell proliferation through the upregulation of cyclin E expression levels. Liver 21:137–142
     [Google Scholar]
  5. Cho J., Baek W., Yang S., Chang J., Sung Y. C., Suh M. 2001b; HCV core protein modulates Rb pathway through pRb down-regulation and E2F-1 up-regulation. Biochimica et Biophysica Acta 1538:59–66
     [Google Scholar]
  6. Chomczynski P., Sacchi N. 1987; Single-step method of RNA isolation by acid guanidinium thiocyanate–phenol–chloroform extraction. Analytical Biochemistry 162:156–159
     [Google Scholar]
  7. Datto M. B., Yu Y., Wang X. F. 1995a; Functional analysis of the transforming growth factor beta responsive elements in the WAF1/Cip1/p21 promoter. Journal of Biological Chemistry 270:28623–28628
     [Google Scholar]
  8. Datto M. B., Li Y., Panus J. F., Howe D. J., Xiong Y., Wang X. F. 1995b; Transforming growth factor beta induces the cyclin-dependent kinase inhibitor p21waf1 through a p53-independent mechanism. Proceedings of the National Academy of Sciences, USA 92:5545–5549
     [Google Scholar]
  9. Gorman C. M., Merlino G. T., Willingham M. C., Pastan I., Howard B. H. 1982; The Rous sarcoma virus long terminal repeat is a strong promoter when introduced into a variety of eukaryotic cells by DNA-mediated transfection. Proceedings of the National Academy of Sciences, USA 79:6777–6781
     [Google Scholar]
  10. Hanyu A., Ishidou Y., Ebisawa T., Shimanuki T., Imamura T., Miyazono K. 2001; The N domain of Smad7 is essential for specific inhibition of transforming growth factor-beta signaling. Journal of Cell Biology 155:1017–1027
     [Google Scholar]
  11. Hayashi J., Aoki H., Kajino K., Moriyama M., Arakawa Y., Hino O. 2000; Hepatitis C virus core protein activates the MAPK/ERK cascade synergistically with tumor promoter TPA, but not with epidermal growth factor or transforming growth factor alpha. Hepatology 32:958–961
     [Google Scholar]
  12. Houghton M. 1996; Hepatitis C virus. In Fields Virology pp 1035–1058 Edited by Fields B. N., Knipe D. M., Howley P. M. Philadelphia: Lippincott–Raven;
     [Google Scholar]
  13. Hu P. P., Datto M. B., Wang X. F. 1998; Molecular mechanisms of transforming growth factor-beta signaling. Endocrine Reviews 19:349–363
     [Google Scholar]
  14. Jung E. Y., Lee M. N., Yang H. Y., Yu D. Y., Jang K. L. 2001; The repressive activity of hepatitis C virus core protein on the transcription of p21(waf1) is regulated by protein kinase A-mediated phosphorylation. Virus Research 79:109–115
     [Google Scholar]
  15. Kwun H. J., Jung E. Y., Ahn J. Y., Lee M. N., Jang K. L. 2001; p53-dependent transcriptional repression of p21waf1 by hepatitis C virus NS3. Journal of General Virology 82:2235–2241
     [Google Scholar]
  16. Lee S. J., Ha M. J., Lee J., Nguyen P., Choi Y. H., Pirnia F., Kang W. K., Wang X. F., Kim S. J., Trepel J. B. 1998; Inhibition of the 3-hydroxy-3-methylglutaryl-coenzyme A reductase pathway induces p53-independent transcriptional regulation of p21(WAF1/CIP1) in human prostate carcinoma cells. Journal of Biological Chemistry 273:10618–10623
     [Google Scholar]
  17. Li J. M., Datto M. B., Shen X., Hu P. P., Yu Y., Wang X. F. 1998; Sp1, but not Sp3, functions to mediate promoter activation by TGF-beta through canonical Sp1 binding sites. Nucleic Acids Research 26:2449–2456
     [Google Scholar]
  18. Lu W., Lo S. Y., Chen M., Wu K., Fung Y. K., Ou J. H. 1999; Activation of p53 tumor suppressor by hepatitis C virus core protein. Virology 264:134–141
     [Google Scholar]
  19. Marusawa H., Hijikata M., Chiba T., Shimotohno K. 1999; Hepatitis C virus core protein inhibits Fas- and tumor necrosis factor alpha-mediated apoptosis via NF-kappaB activation. Journal of Virology 99:4713–4720
     [Google Scholar]
  20. Matsukawa Y., Tokino T., Yamagishi H., Oka T., Nomura H., Sakai T. 1997; Butyrate activates the WAF1/Cip1 gene promoter through Sp1 sites in a p53-negative human colon cancer cell line. Journal of Biological Chemistry 272:22199–22206
     [Google Scholar]
  21. Moriya K., Fulie H., Shintani Y., Yotsuyanagi H., Tsutsumi T., Ishibashi K., Matsuura Y., Kimura S., Miyamura T., Koike K. 1998; The core protein of hepatitis C virus induces hepatocellular carcinoma in transgenic mice. Nature Medicine 4:1065–1067
     [Google Scholar]
  22. Moustakas A., Kardassis D. 1998; Regulation of the human p21/WAF1/Cip1 promoter in hepatic cells by functional interactions between Sp1 and Smad family members. Proceedings of the National Academy of Sciences, USA 95:6733–6738
     [Google Scholar]
  23. Nakano K., Mizuno T., Sowa Y., Orita T., Yoshino T., Okuyama Y., Fujita T., Ohtani-Fujita N., Matsukawa Y., Tokino T., Yamagishi H., Oka T., Nomura H., Sakai T. 1997; Butyrate activates the WAF1/Cip1 gene promoter through Sp1 sites in a p53-negative human colon cancer cell line. Journal of Biological Chemistry 272:22199–22206
     [Google Scholar]
  24. Otsuka M., Kato N., Lan K. H., Yoshida H., Kata J., Goto T., Shiratori Y., Omata M. 2000; Hepatitis C virus core protein enhances p53 function through augmentation of DNA binding affinity and transcriptional ability. Journal of Biological Chemistry 275:34122–34130
     [Google Scholar]
  25. Pardali K., Kurisaki A., Moren A., Dijke P., Kardassis D., Moustakas A. 2000; Role of Smad proteins and transcription factor Sp1 in p21(Waf1/Cip1) regulation by transforming growth factor-beta. Journal of Biological Chemistry 275:29244–29256
     [Google Scholar]
  26. Prowse D. M., Bolgan L., Molnar A., Dotto G. P. 1997; Involvement of the Sp3 transcription factor in induction of p21Cip1/WAF1 in keratinocyte differentiation. Journal of Biological Chemistry 272:1308–1314
     [Google Scholar]
  27. Ray R. B., Lagging L. M., Meyer K., Steele R., Ray R. 1995; Transcriptional regulation of cellular and viral promoters by the hepatitis C virus core protein. Virus Research 7:209–220
     [Google Scholar]
  28. Ray R. B., Meyer K., Ray R. 1996a; Suppression of apoptotic cell death by hepatitis C virus core protein. Virology 226:176–182
     [Google Scholar]
  29. Ray R. B., Lagging L. M., Meyer K., Ray R. 1996b; Hepatitis C virus core protein cooperates with ras and transforms primary rat embryo fibroblasts to tumorigenic phenotype. Journal of Virology 70:4438–4443
     [Google Scholar]
  30. Ray R. B., Steele R., Meyer K., Ray R. 1997; Transcriptional repression of p53 promoter by hepatitis C virus core protein. Journal of Biological Chemistry 272:10983–10986
     [Google Scholar]
  31. Ray R. B., Steele R., Meyer K., Ray R. 1998; Hepatitis C virus core protein represses p21WAF1/Cip1/Sid1 promoter activity. Gene 208:331–336
     [Google Scholar]
  32. Reynisdottir I., Polyak K., Iavarone A., Massague J. 1995; Kip/Cip and Ink4 Cdk inhibitors cooperate to induce cell cycle arrest in response to TGF-beta. Genes & Development 9:1831–1845
     [Google Scholar]
  33. Shih C. M., Chen C. M., Chen S. Y., Lee Y. H. 1995; Modulation of the trans-suppression activity of hepatitis C virus core protein by phosphorylation. Journal of Virology 69:1160–1171
     [Google Scholar]
  34. Tsuchihara K., Hijikata M., Fukuda K., Kuroki T., Yamamoto N., Shimotohno K. 1999; Hepatitis C virus core protein regulates cell growth and signal transduction pathway transmitting growth stimuli. Virology 258:100–107
     [Google Scholar]
  35. Yoshida I., Oka K., Hidajat R., Nagano-Fujii M., Ishido S., Hotta H. 2001; Inhibition of p21/Waf1/Cip1/Sdi1 expression by hepatitis C virus core protein. Microbiology and Immunology 45:689–697
     [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/0022-1317-83-9-2145
Loading
Hepatitis C virus core protein represses the p21 promoter through inhibition of a TGF-β pathway
J. Gen. Virol. 83, 2145 (2002); https://doi.org/10.1099/0022-1317-83-9-2145
/content/journal/jgv/10.1099/0022-1317-83-9-2145
/content/journal/jgv/10.1099/0022-1317-83-9-2145
Loading

Data & Media loading...

Most cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error